HB

Hardik Bhadabhai Soliya

Active Director Director DIN 09009045
DIN 09009045 First appointment Dec 2020 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 1 historical roles
Total affiliations 2 Since Dec 2020
Shareholding value •••• Premium profile

About Hardik Bhadabhai Soliya

Data last updated:

Hardik Bhadabhai Soliya is a Director at Augxen Pharma Private Limited (since 2021). The companies operate in Pharma and Chemicals and Materials. Augxen Pharma Private Limited reported revenue of ₹27.52 Cr (FY 2025). Earlier, Hardik Bhadabhai Soliya was a Designated Partner at Alkalinechem Llp (2020–2024).

DIN 09009045
Primary Designation Director
Industry Pharma
First Appointment 24 Dec 2020
Oldest Company Age 5 yrs
Largest company Augxen Pharma Private Limited · ₹27.52 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Augxen Pharma Private Limited U33110GJ2021PTC124296
Director22 Jul 20212021₹27.52 Cr (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Alkalinechem Llp AAV-2421
Designated Partner24 Dec 20202020Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Augxen Pharma Private Limited
Alkalinechem Llp
Premium access

Shareholding and investment profile for Hardik Bhadabhai Soliya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hardik Bhadabhai Soliya

Hardik Bhadabhai Soliya currently holds 1 directorship: Augxen Pharma Private Limited (Director, since 22 Jul 2021, revenue ₹27.52 Cr (FY 2025)).

Hardik Bhadabhai Soliya was first appointed on 24 Dec 2020 as Designated Partner at Alkalinechem Llp. The most recent appointment on record is 22 Jul 2021 at Augxen Pharma Private Limited.

Hardik Bhadabhai Soliya held 1 earlier board appointment: Alkalinechem Llp (Designated Partner, 24 Dec 2020 to 12 Nov 2024).

The current boards of Hardik Bhadabhai Soliya's companies include Gajera Manishaben Vijaybhai (Augxen Pharma Private Limited), Ranjanaben Patil (Augxen Pharma Private Limited), Savanbhai Devchandbhai Tibadiya (Augxen Pharma Private Limited), Vandanaben Maheshbhai Matholiya (Augxen Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available